You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Valneva starts MHRA regulatory process for COVID-19 vaccine

Valneva has launched rolling submission for initial approval of its COVID-19 vaccine candidate VLA2001 with the UK’s Medicines and Healthcare products Regulatory Agency (MHRA).